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SUMMARY
Virtual Screening (VS) methods can considerably aid Drug Discovery research, predicting how ligands
interact with drug targets.BINDSURF is an efficient and fast blind VS methodology for the determination
of protein binding sites depending on the ligand, that uses the massively parallel architecture of GPUs for
fast unbiased pre-screening of large ligand databases. In this contribution, we provide a performance/cost
model for the execution of this application on both a physical and public cloud infrastructure. With our
model it is possible to determine which is the best infrastructure by means of execution time and costs for
any given problem to be solved by BINDSURF . Conclusions obtained from our study can be extrapolated
to other GPU based VS methodologies.
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1. INTRODUCTION
In clinical research, it is crucial to determine the safety and effectiveness of current drugs and to
accelerate findings in basic research (discovery of new leads and active compounds) into meaningful
health outcomes. Both objectives require to process the large data set of protein structures available
in biological databases such as PDB [1] and also derived from genomic data using techniques
as homology modeling [2]. Screenings in lab and compound optimization are expensive and
slow methods, but bioinformatics can vastly help clinical research for the mentioned purposes by
providing prediction of the toxicity of drugs and activity in non-tested targets, and by evolving
discovered active compounds into drugs for the clinical trials.
This can be achieved thanks to the availability of bioinformatics tools and Virtual Screening (VS)
methods that allow to test all required hypothesis before clinical trials. Nevertheless current Virtual
Screening (VS) methods, such as docking, fail to make good toxicity and activity predictions being
one of the main reasons that they are constrained by the access to computational resources; even the
nowadays fastest VS methods cannot process large biological databases in a reasonable time-frame.
Therefore, these constraints impose serious limitations in many areas of biomedical research.
The use of massively parallel hardware architectures such as Graphics Processing Units (GPUs)
can tremendously overcome this problem. The GPU has become increasingly popular in the high
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performance computing area, by combining impressive computational power with the demanding
requirements of real-time graphics and the lucrative mass-market of the gaming industry [3].
Scientists have exploited this power in arguably every computational domain, and the GPU has
emerged as a key resource in applications where parallelism is the common denominator [4]. To
maintain this momentum, new hardware features have been progressively added by NVIDIA to
their range of GPUs, with the Kepler architecture [5] being the most recent milestone in this path.
Large clusters are adopting the use of these relatively inexpensive and powerful devices as a way
of accelerating computational-intensive parts of the applications. Actually, the fastest supercomputer
nowadays, Titan, placed in the DOE/SC/OAK Ridge National Laboratory at Tennessee (USA) [6],
is equipped with AMD Opteron Processor and the last generation of NVIDIA k20x GPUs. However,
current GPUs have a great impact on the power consumption of the system, as a high-end GPU may
well increase the power consumption of a cluster node up to 30%, which is actually a big issue
already. This is a critical concern especially for very large datacenters, where the cost dedicated to
supply power to such computers represents an important fraction of the Total Cost of Ownership
(TCO) [7].
Moreover, reducing power consumption in these large installations is now becoming an urgent
concern as several governments, like the US or the British ones, are creating taxes targeted to
facilities that consume too much electricity [8, 9]. For instance, some of most famous datacenters
on Internet, such as Google or Facebook among others, consumed about 0.5% of the overall
electricity in the world during 2005. When electricity needed for cooling and power distribution
is also considered, that number increases up to 1% [10]. The research community is also aware
of this issue, and it is making efforts in developing reduced-power installations. For instance, the
GREEN500 list [11] shows the 500 most power efficient computers in the world. In this way, we
can see a clear shift from the traditional metric FLOPS (FLoating point Operations Per Second) to
FLOPS per watt.
Virtualization techniques may provide significant energy savings, as they enable a larger resource
usage by sharing a given hardware among several users, thus reducing the required amount
of instances of that particular device. As a result, virtualization is being increasingly adopted
in datacenters. In particular, cloud computing is an inherently energy-efficient virtualization
technique [12], in which services run remotely in a ubiquitous computing cloud that provides
scalable and virtualized resources. Thus peak loads can be moved to other parts of the cloud and
the aggregation of a cloud’s resources can provide higher hardware utilization [13]. Public cloud
providers offer their services in a pay as you go fashion, and provide an alternative to physical
infrastructures. However, this alternative only becomes real for a specific amount of data and target
execution time.
In this work, we analyze this landscape of computation by targeting a GPU-based Virtual
Screening method called BINDSURF [14]. We propose a performance/cost model for this
application that allows the user to decide which infrastructure, physical or that of a well known
public cloud provider, is the optimal for a given problem type and size. The execution of a GPU
intensive application such as BINDSURF [15] may strain an institution’s budget when processing
great amounts of data. The more computational physical resources or the more time the available
resources are used, the more the total cost is increased. Moreover, an unused local infrastructure
still generates costs.
The rest of the paper is organized as follows. Section 2 briefly introduces the preliminary
knowledge to better understand the rest of the article. Section 3 explains the experiments performed
for crafting the model that is then formulated in Section 4, Section 5 shows the model in action
using realistic conditions and finally, the paper ends with some conclusions and directions for future
work.
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2. RELATED WORK
2.1. Bioinformatics approaches for Drug Discovery
In discovering new leads, compound optimization, toxicity evaluation and additional stages of the
drug discovery process, VS methods screen large databases of molecules to find which ones fit an
established criteria [16]. Among the many available VS methods for this purpose we decided to use
protein-ligand docking [17,18]. Docking simulations are typically carried out on the protein surface
using known methods such Autodock [19], Glide [20] and DOCK [21]. This region is commonly
derived from the position of a particular ligand in the protein-ligand complex, or from the crystal
structure of the protein without any ligand. The main problem of many docking methods is to take
the assumption, once the binding site is specified, that all ligands will interact with the protein in
the same region, discarding completely the other areas of the protein.
BINDSURF [15] overcomes this problem by use of GPUs by dividing the whole protein surface
into arbitrary independent regions (aka spots). Using the parallelism of GPUs a large ligand database
is screened against the target protein over its whole surface simultaneously, and docking simulations
for each ligand are performed simultaneously in all the specified protein spots resulting in new spots
found after the examination of the distribution of scoring function values over the entire protein
surface.
2.2. Exploitation of HPC resources for Bioinformatics applications
High Performance Computing (HPC) platforms are attractive for technical computation for the
ability to produce data parallel solutions and reduce the makespan needed to simulate biological
and chemical processes. Moderately sized, tightly coupled applications can be hosted on large-
scale supercomputing systems. These moderately sized applications are good candidates for cloud
computing. Even with the increased performance of desk-side systems, there is still a need for these
applications to scale [22]. Typical bioinformatics applications are scientific work-flows composed
of programs or services based on known and accepted methods and algorithms [23, 24]. Given this,
unless applications are written for parallel execution, taking advantage of cloud or HPC systems
efficiently will be infeasible [25]. In such cases, applications should use parallelism techniques,
such as data fragmentation [26, 27].
Several approaches for parallelizing bioinformatics applications exist based on Grid solutions
[25, 28, 29]. CloudBLAST [30] uses the MapReduce paradigm to parallelize bioinformatics tools.
Another BLAST execution, AzureBlast [31] uses “Split/Join” patterns. BlastReduce [32] is a
parallel read mapping algorithm using Hadoop [33]. Using Hadoop and MapReduce [33, 34],
Biodoop [35] as a bioinformatics applications suite provides a general-purpose parallelization
technology that successfully handles distributed bioinformatics problems. EvolvingSpace [36] is
a data-centric system for integrating bioinformatics applications. Condor [37], while not a cloud
implementation is a distributed execution engine for applications. In [38] the MapReduce-MPI
library successfully executes BLAST and SOM in parallel. MapReduce [34] is particularly well
adapted to run bioinformatics applications. A study [39] shows that it is common to have execution
of large numbers of independent tasks or tasks that perform minimal inter-task communication in
parallel for the bioinformatics domain.
2.3. The figures of cloud computing
The promise of cloud computing is delivering all the functionality of existing information
technology services, and in fact it enables new functionalities that were previously infeasible, as it
dramatically reduces the up-front costs of computing that deter many organizations from deploying
many cutting-edge IT services [40]. This scale of cost for computing coupled with data centers
operating at 10 to 30 percent of their available computing power and desktop computers at less than
5 percent calls into question asset and power costs. Equally important are maintenance and service
costs that are a steady drain on corporate resources. A recent survey by Gartner Research indicated
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that about two-thirds of the average corporate IT staffing budget goes towards routine support and
maintenance activities [41].
Cloud computing gives researchers advantages from the convergence of computational resource
efficiency where the power of modern computers is used more efficiently through highly scalable
hardware and software resources and the ability to have these resources available on an as-needed
basis with rapid deployment, parallel batch processing, use of compute-intensive applications, and
interactive applications that respond in real-time to user requirements [42].
By employing cloud computing operational cost savings for energy, keeping service
level agreements improves large scale computing acceptability with greater environmental
sustainability [43]. In the case of Amazon, estimates by Hamilton from Amazon Services [44], the
cost and operation based on a three-year amortization schedule (the low end of the industry nominal
schedule of replacement every 3-7 years) account for 53% of the budget. An additional 42% of the
energy costs include direct power consumption (approximately 19%) and cooling infrastructure
(23%) amortized over a 15-year period [45]. In this way, the comparison of the total cost of
ownership between cloud infrastructures and local infrastructures has been recently studied. For
instance, Kashef and Altmann [46] suggest a cost model for hybrid clouds. Strebel and Stage [47]
proposed an economic decision model for business software application. Truong and Dustdar [48]
presented several techniques to estimate costs for several traditional scientific applications.
parts of the cloud and the aggregation of a cloud resources can provide higher hardware usage.
3. EXPERIMENTS
3.1. Experiment definition
We carried out VS calculations using BINDSURF for the direct prediction of binding poses. For
this purpose we chose three different ligands that conveniently represent chemical diversity of large
compound databases. They will be referred to as ligands A, B and C. Ligand A is a blood clotting
co-factor recently discovered by us [49]. Ligand B and ligand C have been extracted from their
Protein Data Bank complexes with the respective IDS 2byr and 3p4w. In the docking calculations
we accounted for different numbers of Monte Carlo steps such as 5, 10, 50, 500, 5000 and 50000.
An optimal value for the steps parameter does not exist for all different ligand types (A, B and C).
Therefore, it is convenient to perform VS calculations using different values of this parameter since
sometimes we might be interested in short simulations (steps = 5, 10, 50) for obtaining qualitative
information about potential hot-spots in the surface screening approach for millions of different
ligands, but in some other situations we might be more interested in obtaining accurate predictions
for a smaller set of ligands, and then use higher values for the steps parameter such as 500, 5000
and 50000. The outcome of a docking simulation performed by BINDSURF for a type A ligand
(PDB ID is 1qcf ) is shown in Figure 1.
3.2. Infrastructure used
Table I. Platforms System Specifications.
(a) Local Machine
Proc.: Intel Xeon E5620@2.4Ghz
Memory: 16GB
2xGPU NVIDIA Tesla C2050
GPU: GF100
Memory Size: 3072 MB
Memory Bandwidth: 144 GB/sec
Stream Processors: 448
Max Power Draw: 238 W
(b) Amazon EC2
Proc.: 2xIntel Xeon X5570@2.93GHz
Memory: 22GB
2xGPU NVIDIA Tesla M2050
GPU: GF100
Memory Size: 3072 MB
Memory Bandwidth: 148.4 GB/sec
Stream Processors: 448
Max Power Draw: 225 W
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Figure 1. Surface screening results for PDB:1QCF. From up left to down right; a) beads represent protein
spots and the color of each bead is related with the value of the scoring function, so colors from red to blue
indicate lower values for the scoring function, b) histogram with the distribution of scoring function values,
c) red and blue molecules represent crystallographic and predicted pose for the ligand, RMSD is lower than
1 Angstrom, and d) depiction of the hydrogen bonds established by the ligand with the closest residues.
The local architecture used to perform our experiments is described in Table Ia. It is formed of an
Intel Xeon E5620 CPU with 4 cores running at 2.4GHz, 16GB of RAM memory and two NVIDIA
Tesla C2050 graphics cards.
The chosen cloud infrastructure is the one offered by Amazon through its Elastic Compute Cloud
services†. As BINDUSRF is coded using CUDA, the Cluster GPU instances were the only possible
choice. The specifications of the GPU provided by Amazon EC2 are displayed on Table Ib. Being
a public cloud provider, Amazon charges per hour of use. Each ”Quadruple Extra Large” instance
(the one providing GPUs) deployed on the US-East Region costs $2.1 per hour‡.
Even though both targeted platforms provide two GPUs on each machine, the experiments were
conducted using just one in order to avoid contention issues.
3.3. Single Experiment Results
In this Section, we show the experiments we have performed on both local and cloud infrastructure
before we develop the local and cloud model. These experiments are based on ten executions of
BINDSURF per ligand, varying the number of Monte carlo steps. Table II shows the execution
time (in minutes) of BINDSURF on both infrastructures. Execution times on the cloud are higher
than in the local infrastructure, yielding ligand type B (2byr) the lowest values and ligand type C
†http://aws.amazon.com/ec2/
‡http://aws.amazon.com/ec2/pricing/
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Table II. Time in minutes when processing different types of ligands in a single machine with different
Monte carlo Steps.
Ligand type A Ligand type B Ligand type C
Steps Local Cloud Local Cloud Local Cloud
5 0.77 1.46 0.66 1.16 0.97 1.75
10 0.77 1.48 0.66 1.17 0.98 1.98
50 0.85 1.56 0.74 1.26 1.05 1.89
500 1.90 2.60 1.83 2.33 2.02 2.86
5000 15.53 16.18 14.71 15.18 14.80 15.60
(3p4w) the highest. As expected, local infrastructure defeats by tight margin cloud infrastructure
mainly due to the overhead introduced by virtualization and communications in the cloud.
Table III. Power consumption for one ligand of each type with different number of simulation steps in the
local machine.
Ligand type A Ligand type B Ligand type C
5 286 289 281
10 286 290 280
50 292 295 283
500 332 333 317
5000 366 363 357
Besides, power consumption in the local machine is shown in Table III. These values are the
average for each set of experiments. The power consumption of the local machine is mainly driven
by both the execution time and the usage of the GPU. The ligand type C, for instance, requires
higher pre-processing time than the rest of ligands, and the energy consumption in this phase is
lower than the energy consumption in the processing phase.
4. EXECUTION MODEL
This Section shows the performance/cost model defined using the results obtained in the previous
Section. The model is categorized by infrastructure (local, cloud) and then by ligand type (l1c4,
2byr, 3p4w).
The model predicts the behavior of BINDSURF when more machines are added to the resource
pool. As the followed workload distribution is very simple, no transfers have been considered,
because the total number of ligands to be processed is divided between the available machines
at the very beginning.
4.1. Local Model
The individual execution time, expressed in minutes, for each ligand of the local model is given by
the formulas 1. These formulas were obtained by fitting the results from Section 3.3.
tlocalA = 10
−8s2A + 0.0029sA + 0.6699
tlocalB = 2 · 10−9s2B + 0.0028sB + 0.5858
tlocalC = 8 · 10−9s2C + 0.0027sC + 0.8765
(1)
where sx is the number of simulation steps for processing a given ligand type (i.e. A, B or C).
Given a number of physical machines m and the processed ligands of a particular type, the
Equation 2 shows the extrapolated total execution time.
Tlocalx =
tlocalx · lx
m
(2)
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where tlocalx is the time obtained for a given ligand x in Equation 1. The number of processed
ligands is represented by lx and the number of physical machines by m.
The local costs can be expressed by the following formula:
Clocalx = Cex + Cmx + Ccx + Cnx (3)
being the total cost the result of adding four different components:
• Cex : energy consumption costs.
Cex = Tlocalx · ex · pe ·m (4)
being ex the energy consumption for a given ligand x and pe the energy price. Both are
expressed per unit of time.
• Cmx : machine market price.
Cmx = p/at · Tlocalx ·m (5)
being p the physical machine market price and at the amortization per unit time. Typical
values for the amortization period of a machine are 2-3 years. Note that, at is based on the
unit time, i.e. if the unit time is minutes at = years · 365 · 24 · 60.
• Ccx : machine collocation costs.
Ccx = (ct ·m+At · d
m
ma
e) · Tlocalx (6)
being ct the collocation and At the administrator salary, both of them expressed by units of
time. The adjustment is completed by specifying how many physical machines are assigned
to an individual administrator (ma). The expression dxe corresponds to the ceiling function
of x.
• Cnx : non usage costs.
Cnx = (m · p/at +m · ei · pe +m · ct +At · d
m
ma
e) · (1− u) · Tlocalx (7)
being ei the energy consumption in idle mode and u the yearly usage rate.
4.2. Cloud Model
The individual execution time per lingand (tcloudx) expressed in minutes is given by the following
formulas:
tcloudA = 10
−7s2A + 0.0022sA + 1.4518
tcloudB = 10
−7s2B + 0.0023sB + 1.464
tcloudC = 10
−7s2C + 0.0021sC + 1.7737
(8)
Like in the local model, these formulas were obtained by fitting the results from Section 3.3.
As these times consider that only a GPU machine instance from Amazon EC2 is used, another
formula is needed for a complete infrastructure deployed in the cloud:
Tcloudx =
tcloudx · lx
i
(9)
where tcloudx is the time obtained for a given ligand x in Equation 8. The number of processed
ligands is represented by lx and the number of machine instances by i.
On the other hand, the cloud usage cost can be expressed by the following formula:
Ccloudx = p · i · d
tcloudx
60
e (10)
where p is the GPU cluster instance price per hour. Also, tcloudx needs to be converted to hours. In
this cloud model a strict usage of the instantiated machines is considered, that is, they are switched
off once the execution of BINDSURF is completed. However, Amazon charges per hour, for this
reason the time value needs to be rounded up.
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5. MODEL COMPARISON
In this Section, we compare both the local and the cloud model by executing BINDSURF for
processing 6,000 different ligands. The number of Montecarlo steps for each BINDSURF simulation
is 5,000. This is the maximum number of steps we have empirically evaluated. Several assumptions
are taken in order to compare those models. They are:
1. A machine from the local infrastructure costs $8,159.55.
2. The amortization period of each of these machines is 3 years.
3. The KW/h price is that of Spain§: $0.1352.
4. The energy consumption in idle mode for a machine from the local infrastructure is 245W/h.
5. The collocation price per machine/year in the local infrastructure is $12,000.
6. The administrator salary is $3,300/month and each administrator is assigned to 100 machines
from the local infrastructure.
7. The Cluster GPU instances from Amazon were launched at the US East region with a cost of
$2.10/h.
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Figure 2. Cost values in dollars for each ligand type in the cloud infrastructure compared to different usage
percentages of the local infrastructure when processing 6,000 ligands and 5,000 Monte Carlo steps.
Figure 2 shows the execution cost (in dollars) for the three types of ligands when increasing the
number of machines. The cloud model is compared to different percentage of the local infrastructure
§http://www.statista.com/statistics/13020/electricity-prices-in-selected-countries/
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Figure 3. C/P values for each ligand type in the cloud infrastructure compared to different usage percentages
of the local infrastructure when processing 6,000 ligands and 5,000 Monte Carlo steps.
usage ranging from 40% to 100%. In the local infrastructure, the costs become stabilized from 100
machines onwards. The administration salary covers his minimum wage that represents to deal with
100 machines. From this point onwards, the cost is linear in the local infrastructure. Although the
number of machines used in the experiments and administrators needed to maintain those machines
are increased, the execution time of the targeted application decreases as well.
It is noteworthy that Amazon charges per hour of use as previously mentioned ($ 2.1per hour).
Therefore, if the execution time of your application is 1.1 hour, Amazon will charge you 2 hours (i.e.
$ 4.2 per hour). The consequence of this rounding method is shown in Figure 2 as price increases in
accordance with the number of machines. As long as more machines are added to the resource pool,
the execution time is equally distributed among them, and thus, it is likely to have more idle hours.
This fact is also reflected in different behaviors of BINDSURF when executing different types
of ligands; i.e. types A, B and C. In this case, ligand type B is the most affected by the rounding
method.
As the model provides performance (by means of time) and cost values, these need to be somehow
compared. A metric (C/P) [50] has been chosen for this. Its values are calculated with the following
formula:
C/P = C · T (11)
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where C and T are the cost and execution time estimated by the model for a given number of
machines. The best infrastructure is that with the lowest C/P value.
Figure 3 shows the C/P value for the cloud infrastructure compared to that of different local usage
percentages (ranging from 40% to 100%) while increasing the number of machines. Considering an
average-high usage of the local infrastructure (60%-70%), cloud turns to be a good solution for
ligand type A. The same happens with ligand type C but in certain cases. The process of ligand
type B should be moved to the cloud only with an average local usage (40%) and in very specific
cases. This is mainly due to the rounding method used for calculating the price according to the
time consumed. The graphs show that system usage is the deterministic variable for system cost that
drives the C/P metric.
CONCLUSIONS AND FUTURE WORK
Bioinformatics is an emerging research area which generates many computational demanding tools.
Obtaining the most performance in their execution is important but optimization through cost
reduction is crucial, even more so with the current economic context. This work aids researches
within the field of Bioinformatics to decide which HPC platforms is the best suited to run their
experiments on. We evaluate two different alternatives: local infrastructure and public clouds
providers like Amazon, analyzing all parameters that are involved in the execution of a given
application on each of them.
Focusing on the physical infrastructure, we have provided an exhaustive cost model that considers
a wide variety of elements and factors, such as energy consumption, administration cost, machine
collocation cost, etc. This allows us to provide a detailed comparison with the execution of the
same application on the infrastructure provided by Amazon, generating a performance/cost model
for them. The main conclusion of this work is that the resource occupancy per year of the local
infrastructure should be quite high (ranging between 50% to 100%) in order to be profitable.
Otherwise, cloud computing is most-cost effective alternative than local computing if the utilization
of resources is under these values. Nonetheless, Cost calculations are different between local and
cloud systems as the variability in charging (the ceiling cost per hour) is not reflected in the local
system price, and thus, it is drastically affected by execution time.
As future work, we plan to port BINDSURF to OpenCL [51], allowing its execution to a
wider variety of heterogeneous computational systems such as multicore CPUs. This way, more
and cheaper instance types from public cloud providers could be harnessed and a more complete
performance/cost model could be fostered. Moreover, other HPC-environments are emerging as a
good alternative to run Bioinformatic tools such as Volunteer Computing in which computer owners
donate their computing resources to a specific project.
ACKNOWLEDGMENTS
This work has been jointly supported by the Fundacio´n Se´neca (Agencia Regional de Ciencia y
Tecnologı´a, Regio´n de Murcia) under grant 15290/PI/2010, and by the Spanish MINECO, the
European Commission FEDER funds under grants TIN2009-14475-C04 and TIN2012-31345 to
G.D.G and J.M.G; the Catholic University of Murcia (UCAM) under grant PMAFI/26/12 to
J.M.C. and H.P.-S.; MEDIANET (Comunidad de Madrid S2009/TIC-1468) and ServiceCloud
(Ministerio de Economı´a y Competitividad TIN2012-31518) J.L.V.-P. Moreover, we have also
used the computing facilities of Extremadura Research Centre for Advanced Technologies (CETA-
CIEMAT), funded by the European Regional Development Fund (ERDF), and the technical support
provided by the Plataforma Andaluza de Bioinforma´tica of the University of Ma´laga
References
Copyright c© 2013 John Wiley & Sons, Ltd. Concurrency Computat.: Pract. Exper. (2013)
Prepared using cpeauth.cls DOI: 10.1002/cpe
A PERFORMANCE/COST MODEL FOR A CUDA DRUG DISCOVERY APPLICATION 11
1. Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE. The Protein Data
Bank. Nucleic Acids Res 2000; 28:235–242.
2. Sanchez R, Sali A. Large-Scale Protein Structure Modeling of the Saccharomyces cerevisiae Genome. Proceedings
Of The National Academy Of Sciences Of The United States Of America Nov 1998; 95(23):13 597–13 602.
3. Garland M, Kirk DB. Understanding Throughput-Oriented Architectures. Commun. ACM November 2010; 53:58–
66.
4. Garland M, Le Grand S, Nickolls J, Anderson J, Hardwick J, Morton S, Phillips E, Zhang Y, Volkov V. Parallel
Computing Experiences with CUDA. IEEE Micro July 2008; 28:13–27.
5. NVIDIA. Whitepaper NVIDIA’s Next Generation CUDA Compute Architecture: Kepler GK110. NVIDIA, 2012.
6. The Top500 superComputers website. http://www.top500.org/ [23 February 2013].
7. Fan X, Weber WD, Barroso LA. Power provisioning for a warehouse-sized computer. Proceedings of the 34th
annual international symposium on Computer architecture, ISCA ’07, ACM: New York, NY, USA, 2007; 13–23,
doi:10.1145/1250662.1250665.
8. John Carey. Obama’s Cap-and-Trade Plan. http://www.businessweek.com/magazine/content/
09\_11/b4123022554346.htm [23 February 2013].
9. Department of Energy and Climate Change, UK. CRC Energy Efficiency Scheme. https://www.gov.uk/
crc-energy-efficiency-scheme [23 February 2013].
10. Koomey JG. Worldwide electricity used in data centers. Environmental Research Letters 2008; 3(3):034 008.
11. The Green500 superComputers website. http://www.green500.org/ [23 February 2013].
12. Hewitt C. ORGs for Scalable, Robust, Privacy-Friendly Client Cloud Computing. IEEE Internet Computing Sep
2008; 12(5):96–99.
13. Berl A, Gelenbe E, Di Girolamo M, Giuliani G, De Meer H, Dang MQ, Pentikousis K. Energy-efficient cloud
computing. The Computer Journal 2010; 53(7):1045–1051.
14. Sa´nchez-Linares I, Pe´rez-Sa´nchez H, Cecilia JM, Garcı´a JM. BINDSURF: A Fast Blind Virtual Screening
Methodology on GPUs. Network Tools and Applications in Biology (NETTAB 2011), Clinical Bioinformatics,
Ricardo Bellazzi and Paolo Romano: Pavia (Italy), 2011; 95–97.
15. Sa´nchez-Linares I, Pe´rez-Sa´nchez H, Cecilia J, Garcı´a J. High-Throughput parallel blind Virtual Screening using
BINDSURF. BMC Bioinformatics 2012; 13(Suppl 14):S13, doi:10.1186/1471-2105-13-S14-S13.
16. Jorgensen W. The Many Roles of Computation in Drug Discovery. Science 2004; 303(5665):1813–1818.
17. Yuriev E, Agostino M, Ramsland PA. Challenges and Advances in Computational Docking: 2009 in Review.
Journal Of Molecular Recognition 2011; 24(2):149–164.
18. Huang SY, Zou X. Advances and Challenges in Protein-Ligand Docking. International journal of molecular
sciences 2010; 11(8):3016–3034.
19. Morris, GM and Goodsell, DS and Halliday, RS and Huey, R and Hart, WE and Belew, RK and Olson, AJ.
Automated docking using a lamarckian genetic algorithm and an empirical binding free energy function. Journal
of Computational Chemistry 1998; 19(14):1639–1662.
20. Friesner RA, Banks JL, Murphy RB, Halgren TA, Klicic JJ, Mainz DT, Repasky MP, Knoll EH, Shelley M, Perry
JK, et al.. Glide: A New Approach For Rapid, Accurate Docking and Scoring: Method and Assessment of Docking
Accuracy. Journal of Medicinal Chemistry 2004; 47(7):1739–1749.
21. Ewing TJA, Makino S, Skillman AG, Kuntz ID. DOCK 4.0: Search strategies for automated molecular docking of
flexible molecule databases. Journal of Computer-Aided Molecular Design 2001; 15(5):411–428.
22. Li J, Humphrey M, Agarwal D, Jackson K, van Ingen C, Ryu Y. eScience in the cloud: A MODIS Satellite Data
Reprojection and Reduction Pipeline in the Windows Azure Platform. Parallel Distributed Processing (IPDPS),
2010 IEEE International Symposium on, 2010; 1 –10.
23. Stevens RD, Tipney AHJ, Wroe BCJ, Oinn ATM, Senger M, Lord CPW, Goble ACA, Brass AA, Tassabehji M.
Exploring Williams-Beuren syndrome using myGrid Jul 2004.
24. da Cruz SMS, Batista V, Da´vila AMR, Silva E, Tosta F, Vilela C, Campos MLM, Cuadrat R, Tschoeke D, Mattoso
M. OrthoSearch: A Scientific Workflow Approach to Detect Distant Homologies on Protozoans. Proceedings of the
2008 ACM symposium on Applied computing, SAC ’08, ACM: New York, NY, USA, 2008; 1282–1286.
25. Krishnan A. GridBLAST: a Globus-based High-throughput Implementation of BLAST in a Grid computing
framework: Research Articles. Concurr. Comput. : Pract. Exper. Nov 2005; 17(13):1607–1623.
26. Meyer L, Rˆssle S, Bisch P, Mattoso M. Parallelism in Bioinformatics Workflows. High Performance Computing
for Computational Science - VECPAR 2004, Lecture Notes in Computer Science, vol. 3402, Dayde´ M, Dongarra J,
Herna´ndez V, Palma JM (eds.). Springer Berlin Heidelberg, 2005; 583–597.
27. Meyer L, Scheftner D, Voeckler J, Mattoso M, Wilde M, Foster I. An Opportunistic Algorithm for Scheduling
Workflows on Grids. High Performance Computing for Computational Science - VECPAR 2006, Lecture Notes
in Computer Science, vol. 4395, Dayde´ M, Palma JM, Coutinho A´L, Pacitti E, Lopes J (eds.). Springer Berlin
Heidelberg, 2007; 1–12.
28. Andrade J, Andersen M, Berglund L, Odeberg J. Applications of Grid Computing in Genetics and Proteomics.
Applied Parallel Computing. State of the Art in Scientific Computing, Lecture Notes in Computer Science, vol.
4699, Ka˚gstro¨m B, Elmroth E, Dongarra J, Was´niewski J (eds.). Springer Berlin Heidelberg, 2007; 791–798.
29. Stockinger H, Pagni M, Cerutti L, Falquet L. Grid Approach to Embarrassingly Parallel CPU-Intensive
Bioinformatics Problems. Proceedings of the Second IEEE International Conference on e-Science and Grid
Computing, E-SCIENCE ’06, IEEE Computer Society: Washington, DC, USA, 2006; 58.
30. Matsunaga A, Tsugawa M, Fortes J. CloudBLAST: Combining MapReduce and Virtualization on Distributed
Resources for Bioinformatics Applications. Proceedings Twelfth International Conference on Intelligent Systems
for Molecular Biology/Third European Conference on Computational Biology, 2008; 222 –229.
31. Lu W, Jackson J, Barga R. AzureBlast: A Case Study of Developing Science Applications on the Cloud.
Proceedings of the 19th ACM International Symposium on High Performance Distributed Computing, HPDC ’10,
ACM: New York, NY, USA, 2010; 413–420.
32. Schatz M. BlastReduce: High Performance Short Read Mapping with MapReduce May 2008.
Copyright c© 2013 John Wiley & Sons, Ltd. Concurrency Computat.: Pract. Exper. (2013)
Prepared using cpeauth.cls DOI: 10.1002/cpe
12 GINE´S D. GUERRERO ET. AL.
33. Lee KH, Lee YJ, Choi H, Chung YD, Moon B. Parallel Data Processing with MapReduce: A Survey. SIGMOD
Rec. Jan 2012; 40(4):11–20.
34. Dean J, Ghemawat S. MapReduce: Simplified Data Processing on Large Clusters. Commun. ACM Jan 2008;
51(1):107–113.
35. Leo S, Santoni F, Zanetti G. Biodoop: Bioinformatics on Hadoop. Parallel Processing Workshops, 2009. ICPPW
’09. International Conference on, 2009; 415 –422.
36. Wang C, Zhou BB, Zomaya AY. EvolvingSpace: A Data Centric Framework for Integrating Bioinformatics
Applications. IEEE Transactions on Computers 2010; 59(6):721–734.
37. Thain D, Tannenbaum T, Livny M. Distributed Computing in Practice: The Condor Experience: Research Articles.
Concurr. Comput. : Pract. Exper. Feb 2005; 17(2-4):323–356.
38. Sul SJ, Tovchigrechko A. Parallelizing BLAST and SOM Algorithms with MapReduce-MPI Library. Parallel and
Distributed Processing Workshops and Phd Forum (IPDPSW), 2011 IEEE International Symposium on, 2011; 481
–489.
39. Qiu X, Ekanayake J, Beason S, Gunarathne T, Fox G, Barga R, Gannon D. Cloud Technologies for Bioinformatics
Applications. Proceedings of the 2nd Workshop on Many-Task Computing on Grids and Supercomputers, MTAGS
’09, ACM: New York, NY, USA, 2009; 6:1–6:10.
40. Staten J. Hollow Out The MOOSE: Reducing Cost With Strategic Rightsourcing Mar 2009.
41. Gartner Research. State of Washington Agency Total Cost of IT Ownership Assessment Jul 2012. http:
//ofm.wa.gov/tco/documents/final\_report.pdf [23 February 2013].
42. Kim W. Cloud Computing: Today and Tomorrow Jan 2009.
43. Deelman E, Singh G, Livny M, Berriman B, Good J. The cost of doing science on the cloud: the montage example.
Proceedings of the 2008 ACM/IEEE conference on Supercomputing, IEEE Press, 2008; 50.
44. Hamilton J. Cooperative Expendable Micro-Slice Servers (CEMS): Low Cost, Low Power Servers for Internet-
Scale Services Jan 2009.
45. Greenberg A, Hamilton J, Maltz DA, Patel P. The cost of a cloud: research problems in data center networks. ACM
SIGCOMM Computer Communication Review 2008; 39(1):68–73.
46. Kashef MM, Altmann J. A cost model for hybrid clouds. Economics of Grids, Clouds, Systems, and Services.
Springer, 2012; 46–60.
47. Strebel J, Stage A. An economic decision model for business software application deployment on hybrid cloud
environments. Multikonferenz Wirtschaftsinformatik 2010 2010; :47.
48. Truong HL, Dustdar S. Composable cost estimation and monitoring for computational applications in cloud
computing environments. Procedia Computer Science 2010; 1(1):2175–2184.
49. Navarro-Ferna´ndez J, Pe´rez-Sa´nchez H, Martı´nez-Martı´nez I, Meliciani I, Guerrero JA, Vicente V, Corral J, Wenzel
W. In Silico Discovery of a Compound with Nanomolar Affinity to Antithrombin Causing Partial Activation and
Increased Heparin Affinity. Journal of Medicinal Chemistry 2012; 55(14):6403–6412, doi:10.1021/jm300621j.
50. Vazquez-Poletti J, Barderas G, Llorente I, Romero P. A Model for Efficient Onboard Actualization of an
Instrumental Cyclogram for the Mars MetNet Mission on a Public Cloud Infrastructure. Proc. PARA2010: State of
the Art in Scientific and Parallel Computing, Reykjavik (Iceland), June 2010, Lecture Notes in Computer Science,
vol. 7133, Springer Verlag, 2012; 33–42.
51. Stone JE, Gohara D, Shi G. OpenCL: A Parallel Programming Standard for Heterogeneous Computing Systems.
IEEE Des. Test May 2010; 12(3):66–73.
Copyright c© 2013 John Wiley & Sons, Ltd. Concurrency Computat.: Pract. Exper. (2013)
Prepared using cpeauth.cls DOI: 10.1002/cpe
